Table 3 |
|||||||
|
Spearman rank correlations between baseline laboratory test findings in postmenopausal women with rheumatoid arthritis |
|||||||
|
Test |
TNF-α |
IL-1Ra |
IL-6 |
sIL-6R |
IGF-1 |
ESR |
Estradiol |
|
|
|||||||
|
Serum TNF-α (pg/ml) |
– |
0.259* |
0.041 |
0.346** |
-0.128 |
0.135 |
-0.042 |
|
Serum IL-1Ra (pg/ml) |
0.259* |
– |
0.338** |
0.434*** |
-0.021 |
0.108 |
0.088 |
|
Serum IL-6 (pg/ml) |
0.041 |
0.338** |
– |
0.261* |
-0.245* |
0.470*** |
0.116 |
|
Serum sIL-6R (pg/ml) |
0.346** |
0.434*** |
0.261* |
– |
-0.207 |
0.115 |
0.145 |
|
Serum IGF-1 (ng/ml) |
-0.128 |
-0.021 |
-0.245* |
-0.207 |
– |
-0.177 |
0.014 |
|
ESR (mm) |
0.135 |
0.108 |
0.470*** |
0.115 |
-0.177 |
– |
0.015 |
|
Serum estradiol (pmol/l) |
-0.042 |
0.088 |
0.116 |
0.145 |
0.014 |
0.015 |
– |
|
|
|||||||
|
*P < 0.05, **P < 0.01, ***P < 0.001. ESR = erythrocyte sedimentation rate; IGF-1 = insulin-like growth factor 1; IL-1Ra = IL-1-receptor antagonist; sIL-6R = soluble IL-6 receptor; TNF-α = tumor necrosis factor α. |
|||||||
|
d'Elia et al. Arthritis Res Ther 2003 5:R202 doi:10.1186/ar761 |
|||||||